Nicole Johnson 5/13/24 Nicole Johnson 5/13/24

FOXG1 Research Foundation ASGCT Recap -> On Track to a FOXG1 Gene Therapy

The FOXG1 Research Foundation is thrilled to share a recap of our participation at the 2024 American Society of Gene and Cell Therapy (ASGCT) conference in Baltimore. This conference marked a significant milestone for our foundation, truly a "coming out party" to Pharma for our commitment to developing a gene therapy for FOXG1 syndrome.

Nicole Johnson 10/21/20 Nicole Johnson 10/21/20

Taysha Gene Therapies Takes on FOXG1 Syndrome!

Taysha Gene Therapies adds FOXG1 syndrome to the pipeline of neurodegenerative CNS disorders; Taysha will develop gene developing gene replacement therapy (TSHA-117) for FOXG1 syndrome, using their novel miRNA target panel.